The Genetic Architecture of High Bone Mass

Abstract

The phenotypic trait of high bone mass (HBM) is an excellent example of the nexus between common and rare disease genetics. HBM may arise from carriage of many 'high bone mineral density [BMD]'-associated alleles, and certainly the genetic architecture of individuals with HBM is enriched with high BMD variants identified through genome-wide association studies of BMD. HBM may also arise as a monogenic skeletal disorder, due to abnormalities in bone formation, bone resorption, and/or bone turnover. Individuals with monogenic disorders of HBM usually, though not invariably, have other skeletal abnormalities (such as mandible enlargement) and thus are best regarded as having a skeletal dysplasia rather than just isolated high BMD. A binary etiological division of HBM into polygenic vs. monogenic, however, would be excessively simplistic: the phenotype of individuals carrying rare variants of large effect can still be modified by their common variant polygenic background, and by the environment. HBM disorders-whether predominantly polygenic or monogenic in origin-are not only interesting clinically and genetically: they provide insights into bone processes that can be exploited therapeutically, with benefits both for individuals with these rare bone disorders and importantly for the many people affected by the commonest bone disease worldwidei.e., osteoporosis. In this review we detail the genetic architecture of HBM; we provide a conceptual framework for considering HBM in the clinical context; and we discuss monogenic and polygenic causes of HBM with particular emphasis on anabolic causes of HBM.

High bone mass and cam morphology are independently related to hip osteoarthritis: findings from the High Bone Mass cohort

“…However, the results of our study do not support this hypothesis and instead provide evidence that the relationship between cam morphology and rHOA is independent of BMD, acting via separate pathways. There is growing evidence that the HBM phenotype is, at least partially, genetically determined and a result of rare monogenic mutations of large effect and/or multiple small-effect polygenic variants [ 26 ]. There is additional evidence that hip shape may be partially genetically determined, and that these genetic influences may overlap with genetic risk factors for osteoarthritis [ 38 ].…”

The Osteosclerosis Challenge: Toothpaste Unveiling Secrets

“…Primary hyperparathyroidism, hypothyroidism, and acromegaly are all possible endocrine causes of osteosclerosis. While fluorosis, renal phosphate wasting, renal osteodystrophy, and Paget's disease of bone represent metabolic causes, whereas hematologic causes include myelofibrosis, mastocytosis, and sickle cell disease (1–3).…”

Diffuse Idiopathic Skeletal Hyperostosis of Cervical Spine with Dysphagia—Molecular and Clinical Aspects

“…Wnt ligands bind to the receptor complex (frizzled and low-density lipoprotein receptor-related protein (LRP5 or LPR6)), causing the release of β-catenin by phosphorylation, which releases it from the multiprotein complex. The accumulation of β-catenin in the cytoplasm and ultimately its translocation to the nucleus result in the activation of target genes [ 8 ]. TGF-β is another signaling pathway involved in the differentiation of bone-forming osteoblasts, skeletal genesis, and bone homeostasis.…”